Reviews 39
Filters:
Rating
Language
Sort:
Most recent
P
3 years ago

My child is in therapy for a period of 6 months. A...

My child is in therapy for a period of 6 months. After only 2 weeks, the drug from Sandoz (Novartis) stopped production because it was considered insufficient.
I stay for 3 days, if I break up I have to repeat it with other drugs. VERY GOOD JOB Novartis Indonesia ....

- it turns out the factory has not been in production since January 2016.

F
3 years ago

OK

F
4 years ago

Just want to ask can you open an order via Novarti...

Just want to ask can you open an order via Novartis for Zykadia medicine (ceretinib) ... and how much is the price ... please inform ... thank you ... if possible I can buy via direct distributor

E
4 years ago

Nice

About Novartis Indonesia

Novartis Indonesia: Providing Innovative Healthcare Solutions to the Indonesian Market

Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide. With a strong presence in over 155 countries, Novartis has been committed to improving and extending people's lives for more than 25 years. Novartis Indonesia is one of its subsidiaries that has been operating in Indonesia since 1970.

Novartis Indonesia is dedicated to providing innovative healthcare solutions that meet the unique needs of Indonesian patients. The company offers a wide range of products and services, including pharmaceuticals, generics, biosimilars, eye care products, and consumer health products.

Pharmaceuticals

Novartis Indonesia's pharmaceutical portfolio includes innovative medicines for various therapeutic areas such as oncology, cardiology, respiratory diseases, neuroscience disorders, dermatology conditions and ophthalmology. The company's commitment to research and development has led to breakthrough treatments for some of the most challenging diseases.

Generics

In addition to its branded pharmaceuticals portfolio, Novartis also offers high-quality generic medicines at affordable prices through its Sandoz division. Sandoz is one of the world's leading manufacturers of generic drugs with a broad range of products covering all major therapeutic areas.

Biosimilars

As part of its commitment to expanding access to high-quality healthcare solutions globally while reducing costs for patients and payers alike; Novartis also offers biosimilar medicines through Sandoz division which are highly similar versions of existing biologic drugs with comparable safety profiles but at lower costs.

Eye Care Products

Novartis' Alcon division provides innovative eye care products such as contact lenses and surgical equipment used by ophthalmologists worldwide. In addition Alcon also produces over-the-counter eye drops under well-known brands like Systane® which help relieve dry eyes symptoms among others.

Consumer Health Products

The company’s Consumer Health Division provides self-care solutions across various categories like pain relief (Voltaren), cough & cold (Theraflu), digestive health (Maalox) etc., helping people take control over their own health by providing them with safe & effective OTC remedies.


Innovation

At Novartis Indonesia innovation plays an important role in everything they do - from developing new treatments that can improve patient outcomes or reduce side effects associated with existing therapies; To finding ways how technology can be leveraged better so as make healthcare more accessible & affordable especially in remote areas where access remains limited due lack infrastructure or resources available locally.


Corporate Social Responsibility

As part their corporate social responsibility initiatives; Novaris works closely with local communities across different regions within country on various projects aimed at improving public health outcomes while promoting sustainable development practices wherever possible.


Conclusion

Overall it’s clear that Novaris’ commitment towards innovation coupled with their focus on delivering quality healthcare solutions makes them an ideal partner for anyone looking improve patient outcomes or reduce overall cost burden associated with managing chronic illnesses etc., especially given their long-standing presence within Indonesian market which gives them deep understanding local dynamics involved when it comes delivering quality care services here!

Novartis Indonesia

Novartis Indonesia

4.1